Invention Grant
- Patent Title: Diagnosing risk of cardiovascular complications using natiuretic peptides
- Patent Title (中): 使用纳利肽诊断心血管并发症的风险
-
Application No.: US11610045Application Date: 2006-12-13
-
Publication No.: US07655416B2Publication Date: 2010-02-02
- Inventor: Georg Hess , Andrea Horsch
- Applicant: Georg Hess , Andrea Horsch
- Applicant Address: US IN Indianapolis
- Assignee: Roche Diagnostics Operations, Inc.
- Current Assignee: Roche Diagnostics Operations, Inc.
- Current Assignee Address: US IN Indianapolis
- Agency: Roche Diagnositcs Operations, Inc.
- Agent Marilyn Amick
- Priority: EP04013954 20040615
- Main IPC: G01N33/53
- IPC: G01N33/53
Abstract:
The present invention relates to the use of cardiac hormones, particularly natriuretic peptides, for diagnosing the risk of suffering from a cardiovascular complication, particularly heart disease or acute coronary syndrome, as a consequence of cardiotoxic medication, in particular chemotherapeutics, including anthracyclines. In particular, the invention relates to a method for diagnosing the risk of a patient who is going to receive cardiotoxic medication of suffering from a cardiovascular complication as a consequence of the cardiotoxic medication, comprising the steps of (a) taking a body fluid or tissue sample, and (b) measuring, preferably in vitro, the level of a cardiac hormone. Preferred cardiac hormones in the context of the present invention are ANP, NT-proANP, BNP, and NT-proBNP.
Public/Granted literature
- US20070190573A1 DIAGNOSING RISK OF CARDIOVASCULAR COMPLICATIONS USING NATIURETIC PEPTIDES Public/Granted day:2007-08-16
Information query
IPC分类:
